MENU
+Compare
AZN
Stock ticker: NASDAQ
AS OF
Sep 24, 04:59 PM (EDT)
Price
$75.36
Change
-$0.61 (-0.80%)
Capitalization
240.02B

AZN AstraZeneca PLC Forecast, Technical & Fundamental Analysis

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999... Show more

AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AZN with price predictions
Sep 23, 2025

AZN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 15, 2025

AZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where AZN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AZN's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AZN advanced for three days, in of 350 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 283 cases where AZN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AZN as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AZN turned negative on September 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

AZN moved below its 50-day moving average on September 23, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.266) is normal, around the industry mean (9.505). P/E Ratio (28.614) is within average values for comparable stocks, (23.728). Projected Growth (PEG Ratio) (0.877) is also within normal values, averaging (1.818). Dividend Yield (0.021) settles around the average of (0.028) among similar stocks. P/S Ratio (4.203) is also within normal values, averaging (3.454).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AZN is expected to report earnings to fall 47.00% to $1.15 per share on November 06

AstraZeneca PLC AZN Stock Earnings Reports
Q3'25
Est.
$1.15
Q2'25
Beat
by $1.08
Q1'25
Beat
by $1.39
Q4'24
Beat
by $1.03
Q3'24
Beat
by $1.06
The last earnings report on July 29 showed earnings per share of $2.17, beating the estimate of $1.09. With 1.30M shares outstanding, the current market capitalization sits at 240.02B.
A.I.Advisor
published Dividends

AZN paid dividends on September 08, 2025

AstraZeneca PLC AZN Stock Dividends
А dividend of $0.51 per share was paid with a record date of September 08, 2025, and an ex-dividend date of August 08, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
89900
Web
https://www.astrazeneca.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNFI29.490.62
+2.15%
United Natural Foods
BPYPP15.580.22
+1.43%
Brookfield Property Partners LP
ELAN18.54-0.49
-2.57%
Elanco Animal Health
DFDV15.11-0.55
-3.51%
DeFi Development Corp
ARTV2.59-0.11
-4.07%
Artiva Biotherapeutics Inc

AZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-1.97%
GSK - AZN
62%
Loosely correlated
-0.95%
NVS - AZN
61%
Loosely correlated
-0.44%
SNY - AZN
48%
Loosely correlated
-0.28%
PFE - AZN
45%
Loosely correlated
+0.37%
LLY - AZN
41%
Loosely correlated
-1.06%
More